Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-26T12:35:27.571Z Has data issue: false hasContentIssue false
  • English
  • Français

Neonatal Bacteremia: Patterns of Antibiotic Resistance

Published online by Cambridge University Press:  02 January 2015

Ruben Bromiker ,
Ilan Arad ,
Ofra Peleg ,
Aviya Preminger  and
Dan Engelhard
Ruben Bromiker*
Affiliation:
Departments of Neonatology and Pediatrics, Hadassah University Hospitals, Jerusalem, Israel
Ilan Arad
Affiliation:
Departments of Neonatology and Pediatrics, Hadassah University Hospitals, Jerusalem, Israel
Ofra Peleg
Affiliation:
Departments of Neonatology and Pediatrics, Hadassah University Hospitals, Jerusalem, Israel
Aviya Preminger
Affiliation:
Departments of Neonatology and Pediatrics, Hadassah University Hospitals, Jerusalem, Israel
Dan Engelhard
Affiliation:
Departments of Neonatology and Pediatrics, Hadassah University Hospitals, Jerusalem, Israel
*
Department of Neonatology, Hadassah University Hospital, Mount Scopus, 91240 Jerusalem, Israel
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine the incidence and evaluate the antimicrobial-susceptibility patterns of bacterial infections in our neonatal units.

Design:

Retrospective surveillance study.

Setting:

The neonatal units of the Hadassah University Hospitals, Jerusalem, Israel.

Patients:

All newborns admitted from January 1994 through February 1999.

Methods:

The records of all patients with positive blood and cerebrospinal fluid cultures were reviewed. Bacteremia was considered early-onset (vertical) when occurring within the first 72 hours of life and late-onset (nosocomial) when occurring later. The prevalence and antibiotic-resistance patterns of vertically transmitted and nosocomially acquired strains were compared and studied over time.

Results:

219 of 35,691 newborn infants had at least one episode of bacteremia (6.13/1,000 live births). There were 305 identified organisms, of which 21% (1.29/1,000 live births) were considered vertically transmitted and 79% nosocomially acquired. The most common organism causing early-onset disease (29.2%) was group B streptococcus (0.38/1,000 live births), whereas coagulase-negative staphylococci (51%) were the most prevalent in late-onset disease. All gram-positive bacteria were susceptible to vancomycin. Most gram-positive organisms other than staphylococci were susceptible to ampicillin. Gram-negative organisms represented 31% of all isolates. Generally, there was a trend of increasing resistance to commonly used antibiotics among nosocomially acquired gram-negative organisms, compared to those vertically transmitted, with statistically significant differences for ampicillin and mezlocillin (P<.05 and P<.01, respectively). Over the years, a trend toward an increasing resistance to antibiotics was observed among gram-negative organisms.

Conclusions:

The trend of increasing bacterial resistance to commonly used antibiotics necessitates the implementation of a rational empirical treatment strategy, based on local susceptibility data, reserving certain agents for emerging resistant pathogens.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 22 , Issue 12 , December 2001 , pp. 767 - 770
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Freedman, RM, Ingram, DL, Gross, I, Ehrenkranz, RA, Warshaw, JB, Baltimore, RS. A half century of neonatal sepsis at Yale. Am J Dis Child 1981;135:140–144.CrossRefGoogle ScholarPubMed
2. Kumar, SP, Delivoria-Papadopoulos, M. Infections in newborn infants in a special care unit: a changing pattern of infection. Ann Clin Lab Sci 1985;15:351–356.Google Scholar
3. Spigelblatt, L, Saintonge, J, Chicoine, R, Laverdiere, M. Changing pattern of neonatal streptococcal septicemia. Pediatr Infect Dis J 1985;4:56–58.CrossRefGoogle ScholarPubMed
4. Eidelman, AI, Reynolds, J. Gentamicin-resistant Klebsiella infections in a neonatal intensive care unit. Am J Dis Child 1978;132:421–422.Google Scholar
5. Gladstone, IM, Ehrenkranz, RA, Edberg, SC, Baltimore, RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990;9:819–825.CrossRefGoogle ScholarPubMed
6. Klein, JO. Current antibacterial treatment for neonatal sepsis and meningitis. Pediatr Infect Dis J 1990;9:783–784.CrossRefGoogle ScholarPubMed
7. American Academy of Pediatrics. Escherichia coli and other gram-negative bacilli. In: Peter, G, ed. 1997 Red Booh: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997:202–204.Google Scholar
8. Yu, VY. Neonatal sepsis and infection control policies in Australia. J Paediatr Child Health 1990;26:252–256.CrossRefGoogle ScholarPubMed
9. Freij, BJ, McCracken, GH Jr. Acute infections. In: Avery, GB, Fletcher, MA, MacDonald, MG, eds. Neonatology. Philadelphia, PA: JB Iippincott Co; 1994:1083.Google Scholar
10. Huang, FY, Wang, CH, Chiu, NC. Coagulase-negative staphylococcal septicemia [in Chinese]. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1994;35:423–428.Google ScholarPubMed
11. Bruun, B, Paerregaard, A. Septicemia in a Danish neonatal intensive care unit, 1984 to 1988. Pediatr Infect Dis J 1991;10:159–160.CrossRefGoogle Scholar
12. Cordero, L, Sananes, M, Ayers, LW. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol 1999;20:242–246.CrossRefGoogle Scholar
13. Tullus, K, Olsson-Liljequist, B, Lundstrom, G, Burman, LG. Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Acta Paediatr Scand 1990;80:205–212.CrossRefGoogle Scholar
14. Ashkenazi, S, Leibovici, L, Churi, C, Drucker, M, Konisberger, H, Samra, Z. Childhood bacteremia in Israel: causes, age relation, predisposing factors and source. Isr J Med Sci 1994;30:610–616.Google ScholarPubMed
15. Klein, JO. Bacteriology of neonatal sepsis. Pediatr Infect Dis J 1990;9:778.CrossRefGoogle ScholarPubMed
16. Suarez Escandon, A, Perez Amarillo, J, Valdes-Dapena Vivanco, M. Bacterial agents most frequently isolated from hospitalized newborns [in Spanish]. Rev Cubana Med Trop 1989;41:284–289.Google ScholarPubMed
17. Klein, JF, Shahrivar, F. Use of percutaneous silastic central venous catheters in neonates and the management of infectious complications. Am J Perinatol 1992;9:261–264.CrossRefGoogle ScholarPubMed
18. Low, DE, Schmidt, BK, Kirpalani, HM, Moodie, R, Kreiswirth, B, Matlow, A, et al. An endemic strain of Staphylococcus haemolyticus colonizing and causing bacteremia in neonatal intensive care unit patients. Pediatrics 1992;89:696–700.CrossRefGoogle ScholarPubMed
19. Kurlat, I, Stoll, BJ, McGowan, JE Jr. Time to positivity for detection of bacteremia in neonates. J Clin Microbiol 1989;27:1068–1071.CrossRefGoogle ScholarPubMed
20. Huebner, J, Pier, GB, Maslow, JN, Muller, E, Shiro, H, Parent, M, et al. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis 1994;169:526–531.CrossRefGoogle Scholar
21. Ginovart Galiana, G, Andreu Duat, MD, Farre Riba, R, Mangues Bafalluy, A, Demestre Guasch, X, Raspall Torrent, F, et al. Sepsis caused by coagulase-negative Staphylococcus in the newborn infant: clinical and therapeutic aspects. An Esp Pediatr 1993;38:488–492.Google ScholarPubMed
22. Dobson, SR, Baker, CJ. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics 1990;85:165–171.CrossRefGoogle ScholarPubMed
23. Christ, W, Lehnert, T, Ulbrich, B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988;10(suppl):141–146.CrossRefGoogle ScholarPubMed
24. Schaad, UB, Stoupis, C, Wedgwood, J, Tschaeppeler, H, Vock, P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J 1991;10:723–729.Google ScholarPubMed
25. Lentnek, AL, Williams, RR. Aztreonam treatment of gram-negative bacterial meningitis. Rev Infect Dis 1991;13(suppl 7):S586–S591.CrossRefGoogle ScholarPubMed
26. Sklavunu Tsurutsoglu, S, Gatzola-Karaveli, M, Hatziioannidis, K, Tsurutsoglu, G. Efficacy of aztreonam in the treatment of neonatal sepsis. Rev Infect Dis 1991;13(suppl 7):S591–S593.CrossRefGoogle ScholarPubMed
27. Stutman, HR. Clinical experience with aztreonam for treatment of infections in children. Rev Infect Dis 1991;13(suppl 7):S582–S585.CrossRefGoogle ScholarPubMed